SCHEMBL19857060

SCHEMBL19857060

CCC(c1cccc(OCc2ccccc2)c1)C(C)C(=O)O

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
ALOX5 P09917 1/20 0.55
MAOB P27338 3/20 0.52
NR4A2 P43354 1/20 0.51
MME P08473 1/20 0.51
ACE P12821 1/20 0.51
CPA1 P15085 1/20 0.51
ACE2 Q9BYF1 1/20 0.51
FFAR1 O14842 1/20 0.49
MEN1 O00255 1/20 0.49
BCHE P06276 1/20 0.49
PTGES O14684 1/20 0.48
LTB4R Q15722 1/20 0.47
LTB4R2 Q9NPC1 1/20 0.47
TSHR P16473 1/20 0.47
SMPD1 P17405 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19857059 1.00 KMT2A (0.56) KMT2ASMN1; SMN2ALOX5MAOBNR4A2
SCHEMBL23747953 0.88 ALOX5 (0.56) KMT2ASMN1; SMN2ALOX5MAOBNR4A2
SCHEMBL16825380 0.88 ALOX5 (0.56) KMT2ASMN1; SMN2ALOX5MAOBNR4A2
SCHEMBL2505640 0.84 PSEN1 (0.44) KMT2ASMN1; SMN2ALOX5MAOBMME
SCHEMBL2505243 0.84 PSEN1 (0.44) KMT2ASMN1; SMN2ALOX5MAOBMME
SCHEMBL16871046 0.84 BCHE (0.53) KMT2ASMN1; SMN2ALOX5MAOBNR4A2
SCHEMBL16871064 0.84 BCHE (0.53) KMT2ASMN1; SMN2ALOX5MAOBNR4A2
SCHEMBL15474062 0.83 ALOX5 (0.55) KMT2ASMN1; SMN2ALOX5PTGES
SCHEMBL18371748 0.83 BCHE (0.53) KMT2ASMN1; SMN2ALOX5MAOBNR4A2
SCHEMBL29763585 0.83 BCHE (0.53) KMT2ASMN1; SMN2ALOX5MAOBNR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2943454-B1 TAPENTADOL MALEATE AND CRYSTALLINE FORMS THEREOF KRKA TOVARNA ZDRAVIL D D (SI) 2021-08-18 EP disclosed
EP-3083551-B1 CRYSTALLINE FORM OF TAPENTADOL INTERMEDIATE FARMA GRS D O O (SI) 2018-02-14 EP disclosed
CN-103339116-B Substituted n-valeramide compound, preparation method and application thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2016-04-06 CN disclosed